Axon Enterprise, Inc (NASDAQ:AXON) Stock Holdings Lowered by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. lessened its position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 27.6% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 7,500 shares of the biotechnology company's stock after selling 2,852 shares during the period. Oppenheimer & Co. Inc.'s holdings in Axon Enterprise were worth $3,945,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in AXON. Fourth Dimension Wealth LLC acquired a new stake in shares of Axon Enterprise during the 4th quarter valued at approximately $30,000. Elequin Capital LP bought a new stake in Axon Enterprise during the fourth quarter valued at $46,000. CoreFirst Bank & Trust bought a new stake in Axon Enterprise during the fourth quarter valued at $59,000. Global Financial Private Client LLC raised its holdings in shares of Axon Enterprise by 11,100.0% during the first quarter. Global Financial Private Client LLC now owns 112 shares of the biotechnology company's stock worth $59,000 after purchasing an additional 111 shares during the period. Finally, MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH bought a new position in shares of Axon Enterprise in the 1st quarter worth about $77,000. Institutional investors and hedge funds own 79.08% of the company's stock.

Analysts Set New Price Targets

Several research analysts have recently commented on AXON shares. Needham & Company LLC lifted their price target on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a report on Thursday, May 8th. Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Bank of America raised their price target on Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a report on Wednesday, June 4th. Barclays boosted their price objective on Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. Finally, The Goldman Sachs Group increased their target price on Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have issued a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $699.55.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of the business's stock in a transaction dated Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the sale, the chief executive officer now directly owns 3,063,982 shares in the company, valued at approximately $1,657,583,622.18. The trade was a 0.33% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, President Joshua Isner sold 905 shares of the company's stock in a transaction that occurred on Tuesday, June 17th. The stock was sold at an average price of $776.39, for a total transaction of $702,632.95. Following the completion of the sale, the president now directly owns 268,735 shares of the company's stock, valued at approximately $208,643,166.65. This represents a 0.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 44,642 shares of company stock worth $30,500,428 in the last 90 days. Corporate insiders own 4.40% of the company's stock.

Axon Enterprise Stock Performance

AXON stock traded up $18.88 on Thursday, reaching $803.95. The company's stock had a trading volume of 483,661 shares, compared to its average volume of 710,451. The firm has a fifty day moving average of $704.90 and a two-hundred day moving average of $628.19. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.83 and a quick ratio of 2.62. The company has a market capitalization of $62.59 billion, a P/E ratio of 194.19, a price-to-earnings-growth ratio of 91.43 and a beta of 1.29. Axon Enterprise, Inc has a 52 week low of $279.02 and a 52 week high of $806.64.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.34 by $0.07. The company had revenue of $603.63 million during the quarter, compared to analysts' expectations of $585.67 million. Axon Enterprise had a return on equity of 5.81% and a net margin of 14.86%. The company's revenue for the quarter was up 31.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.15 earnings per share. As a group, analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.